A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Med J. Chen, X.
- Brain tumor - Wikipedia!
- People Tools: 54 Strategies for Building Relationships, Creating Joy, and Embracing Prosperity.
- Liquid biopsy for pediatric central nervous system tumors | npj Precision Oncology!
Microsatellite alterations in plasma DNA of small cell lung cancer patients. Mansilla, C. Ferreira, M. Circulating tumor cell technologies. Zhang, W. Liquid biopsy for cancer: circulating tumor cells, circulating free DNA or exosomes? Schilling, D. Isolated, disseminated and circulating tumour cells in prostate cancer.
Ortiz, V. Analyzing circulating tumor cells one at a time. Trends Cell Biol. Ignatiadis, M. Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility. Hashimoto, M. Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood pvCTC during surgical manipulation in non-small cell lung cancer.
Reference Manual on Scientific Evidence: Third Edition
Volik, S. Mehrotra, M. Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors. Oncotarget 9 , — Valpione, S. Plasma total cell-free DNA cfDNA is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients. Cancer 88 , 1—9 Gorgannezhad, L. Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies. Diehl, F. Circulating mutant DNA to assess tumor dynamics.
Underhill, H. Fragment length of circulating tumor DNA. Jahr, S. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Tabernero, J. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Lancet Oncol. Grasselli, J. Klein-Scory, S. Significance of liquid biopsy for monitoring and therapy decision of colorectal cancer.
Oxnard, G. Association between plasma genotyping and outcomes of treatment with osimertinib AZD in advanced non-small-cell lung cancer. Krug, A.
Olsson, E. Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease. EMBO Mol. Schwaederle, M. Detection rate of actionable mutations in diverse cancers using a biopsy-free blood circulating tumor cell DNA assay. Oncotarget 7 , — Martinez-Ricarte, F. Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor dna from cerebrospinal fluid.
Huang, T. Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Panditharatna, E. Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy. CCR Manda, S. Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas.
Figueroa, J. Zhang, J. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Rapisuwon, S. Circulating biomarkers to monitor cancer progression and treatment. Drusco, A. Oncotarget 6 , — Shalaby, T. Detection and quantification of extracellular microRNAs in medulloblastoma. Cancer Metastas-. Akers, J. A cerebrospinal fluid microRNA signature as biomarker for glioblastoma.cadmortconssmok.tk
Join Kobo & start eReading today
Oncotarget 8 , — Teplyuk, N. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity.
Tang, Y. Plasma miR as a potential diagnostic and prognostic indicator in human glioma.
Tumors of the Central Nervous System, Volume 3: Brain Tumors (Part 1) - PDF Drive
Fernando, M. New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes. Manterola, L. Wang, H. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. Epigenetics 10 , 59 Santangelo, A.
- Tumor Types - National Brain Tumor Society?
- Genes tested!
- Contemporary Feminist Theatres: To Each Her Own (Gender and Performance);
A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker. Mallawaaratchy, D. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease. Schwanhausser, B. Global quantification of mammalian gene expression control. Di Meo, A. Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Cancer 16 , 80 Jimenez-Luna, C. Proteomic biomarkers in body fluids associated with pancreatic cancer. Kuppusamy, P.
Proteins are potent biomarkers to detect colon cancer progression. Saudi J. Van Raemdonck, G.
Grade I – Pilocytic Astrocytoma
Identification of protein biomarkers for cervical cancer using human cervicovaginal fluid. Humphries, J. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer. Acta , — Saratsis, A. Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid.
Related Tumors of the Central Nervous System, Volume 3: Brain Tumors (Part 1)
Copyright 2019 - All Right Reserved